Share Price and Basic Stock Data
Last Updated: January 17, 2026, 2:15 pm
| PEG Ratio | 0.43 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Modi Naturals Ltd operates in the edible oils and solvent extraction industry, with its current market capitalization reported at ₹466 Cr and a share price of ₹350. The company reported a trailing twelve months (TTM) revenue of ₹671 Cr, showing a notable increase from ₹399 Cr in FY 2024 and ₹418 Cr in FY 2023. Quarterly sales figures indicate fluctuations, with the highest quarterly sales of ₹114 Cr recorded in December 2022, followed by a drop to ₹84 Cr in June 2023. However, the sales have shown a consistent upward trend in FY 2025, reaching ₹190 Cr in March 2025. The operating profit margin (OPM) is currently at 10%, while the return on equity (ROE) stands at 29.2%, indicating robust profitability relative to shareholder equity. Overall, the revenue trajectory reflects a recovery and growth phase, aligning with the company’s strategic positioning in the edible oils market.
Profitability and Efficiency Metrics
Modi Naturals Ltd has demonstrated significant improvement in its profitability metrics, with a net profit of ₹37 Cr reported for the latest fiscal year, a substantial increase compared to the previous year’s net profit of ₹1 Cr. The company’s earnings per share (EPS) surged to ₹23.32 in FY 2025 from a low of ₹0.85 in FY 2023, reflecting a strong rebound. The operating profit margin has also improved, standing at 8% in FY 2025 compared to just 1% in FY 2023. The interest coverage ratio (ICR) is reported at 4.89x, indicating that the company can comfortably meet its interest obligations, which stood at ₹12 Cr for FY 2025. The cash conversion cycle (CCC) has significantly reduced from 117 days in FY 2024 to 66 days in FY 2025, showcasing enhanced operational efficiency. These metrics underscore Modi Naturals’ ability to improve profit margins and manage operational costs effectively.
Balance Sheet Strength and Financial Ratios
The balance sheet of Modi Naturals Ltd reflects a solid financial foundation, with total assets reported at ₹353 Cr and total liabilities at ₹330 Cr. The company has reserves of ₹129 Cr, which have steadily increased from ₹69 Cr in FY 2023, providing a cushion for future investments and operational needs. However, borrowings have also risen to ₹152 Cr, up from ₹142 Cr in FY 2023, indicating a higher leverage level. The debt-to-equity ratio stands at 1.22x, which is relatively high compared to industry norms, suggesting potential risks related to financial leverage. The current ratio is reported at 1.22x, indicating adequate short-term liquidity, while the quick ratio is at 0.57x, suggesting a tighter liquidity position. Overall, while the company shows strong asset growth and profitability, its increasing debt levels warrant careful monitoring.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Modi Naturals Ltd reveals a strong promoter holding of 69.09%, indicating a significant commitment from the company’s founders. The public holds 30.90% of the shares, while foreign institutional investors (FIIs) have not reported any holdings, and domestic institutional investors (DIIs) have decreased their stake to 0.00% as of the latest reporting period. The number of shareholders has increased to 6,634, reflecting growing interest in the company. This strong promoter backing can instill confidence among retail investors, but the absence of institutional support may raise concerns regarding the stock’s stability. The fluctuations in the shareholding pattern, particularly the decline in DII participation, could signal a cautious outlook from professional investors regarding the company’s growth prospects.
Outlook, Risks, and Final Insight
Looking ahead, Modi Naturals Ltd is poised for continued growth, particularly with the upward trend in sales and profitability metrics. The company’s focus on operational efficiency and cost management, as evidenced by reduced CCC and improved margins, positions it favorably in the competitive edible oils sector. However, risks include increasing leverage, as indicated by rising borrowings, and potential volatility in commodity prices affecting raw material costs. The lack of institutional investor support may also pose challenges in terms of stock liquidity and market perception. To sustain its growth momentum, Modi Naturals must navigate these challenges while capitalizing on market opportunities. Overall, the company is on a recovery path, with a solid foundation for future growth contingent on effective risk management and strategic investments.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modi Naturals Ltd | 468 Cr. | 352 | 610/320 | 12.8 | 107 | 0.00 % | 18.7 % | 29.2 % | 10.0 |
| IEL Ltd | 104 Cr. | 7.97 | 10.3/4.00 | 3.37 | 0.00 % | 2.51 % | 1.91 % | 1.00 | |
| Evexia Lifecare Ltd | 312 Cr. | 1.66 | 3.58/1.52 | 218 | 3.02 | 0.00 % | 0.30 % | 0.32 % | 1.00 |
| Diligent Industries Ltd | 64.1 Cr. | 2.69 | 3.95/1.45 | 25.0 | 2.79 | 0.00 % | 7.06 % | 6.09 % | 1.00 |
| CIAN Agro Industries & Infrastructure Ltd | 3,919 Cr. | 1,400 | 3,633/321 | 1,931 | 33.0 | 0.00 % | 8.54 % | 1.06 % | 10.0 |
| Industry Average | 9,665.80 Cr | 171.76 | 149.61 | 37.26 | 0.18% | 14.31% | 12.90% | 4.29 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 93 | 114 | 110 | 84 | 92 | 104 | 120 | 148 | 147 | 179 | 190 | 155 | 147 |
| Expenses | 91 | 113 | 113 | 81 | 90 | 106 | 114 | 134 | 133 | 166 | 174 | 137 | 132 |
| Operating Profit | 2 | 1 | -2 | 2 | 2 | -1 | 6 | 13 | 13 | 13 | 16 | 18 | 15 |
| OPM % | 2% | 1% | -2% | 3% | 2% | -1% | 5% | 9% | 9% | 7% | 8% | 11% | 10% |
| Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 1 | 0 | -3 | 1 | 1 | -5 | 1 | 9 | 9 | 9 | 11 | 13 | 12 |
| Tax % | 25% | 0% | -13% | 16% | 16% | -15% | 6% | 14% | 15% | 12% | 27% | 22% | 15% |
| Net Profit | 1 | 0 | -2 | 1 | 1 | -4 | 1 | 7 | 8 | 8 | 8 | 10 | 10 |
| EPS in Rs | 0.60 | 0.01 | -1.83 | 0.62 | 0.60 | -3.15 | 0.95 | 5.61 | 5.70 | 5.88 | 6.13 | 7.88 | 7.57 |
Last Updated: January 6, 2026, 7:05 pm
Below is a detailed analysis of the quarterly data for Modi Naturals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 147.00 Cr.. The value appears to be declining and may need further review. It has decreased from 155.00 Cr. (Jun 2025) to 147.00 Cr., marking a decrease of 8.00 Cr..
- For Expenses, as of Sep 2025, the value is 132.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 137.00 Cr. (Jun 2025) to 132.00 Cr., marking a decrease of 5.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Jun 2025) to 15.00 Cr., marking a decrease of 3.00 Cr..
- For OPM %, as of Sep 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 11.00% (Jun 2025) to 10.00%, marking a decrease of 1.00%.
- For Other Income, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 2.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Jun 2025) to 12.00 Cr., marking a decrease of 1.00 Cr..
- For Tax %, as of Sep 2025, the value is 15.00%. The value appears to be improving (decreasing) as expected. It has decreased from 22.00% (Jun 2025) to 15.00%, marking a decrease of 7.00%.
- For Net Profit, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 10.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 7.57. The value appears to be declining and may need further review. It has decreased from 7.88 (Jun 2025) to 7.57, marking a decrease of 0.31.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:28 am
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Sales | 443 | 474 | 418 | 399 | 663 | 671 |
| Expenses | 430 | 459 | 412 | 390 | 607 | 608 |
| Operating Profit | 13 | 15 | 5 | 9 | 56 | 62 |
| OPM % | 3% | 3% | 1% | 2% | 8% | 9% |
| Other Income | 4 | 1 | 2 | 1 | 1 | 2 |
| Interest | 1 | 2 | 4 | 7 | 12 | 11 |
| Depreciation | 1 | 1 | 2 | 4 | 8 | 8 |
| Profit before tax | 14 | 13 | 2 | -2 | 38 | 45 |
| Tax % | 25% | 28% | 42% | -21% | 18% | |
| Net Profit | 11 | 9 | 1 | -1 | 31 | 37 |
| EPS in Rs | 8.31 | 7.40 | 0.85 | -1.04 | 23.32 | 27.46 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% |
YoY Net Profit Growth
| Year | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|
| YoY Net Profit Growth (%) | -18.18% | -88.89% | -200.00% | 3200.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -70.71% | -111.11% | 3400.00% |
Modi Naturals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| TTM: | 45% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 49% |
| TTM: | 544% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 53% |
| 3 Years: | 33% |
| 1 Year: | 53% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 11% |
| Last Year: | 29% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: December 4, 2025, 3:08 am
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 55 | 65 | 69 | 77 | 108 | 129 |
| Borrowings | 21 | 51 | 142 | 170 | 149 | 152 |
| Other Liabilities | 33 | 37 | 38 | 46 | 59 | 59 |
| Total Liabilities | 121 | 165 | 263 | 306 | 330 | 353 |
| Fixed Assets | 19 | 26 | 27 | 149 | 145 | 141 |
| CWIP | 0 | 0 | 91 | 0 | 16 | 54 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 102 | 139 | 144 | 157 | 169 | 158 |
| Total Assets | 121 | 165 | 263 | 306 | 330 | 353 |
Below is a detailed analysis of the balance sheet data for Modi Naturals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Reserves, as of Sep 2025, the value is 129.00 Cr.. The value appears strong and on an upward trend. It has increased from 108.00 Cr. (Mar 2025) to 129.00 Cr., marking an increase of 21.00 Cr..
- For Borrowings, as of Sep 2025, the value is 152.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 149.00 Cr. (Mar 2025) to 152.00 Cr., marking an increase of 3.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 59.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 59.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 353.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 330.00 Cr. (Mar 2025) to 353.00 Cr., marking an increase of 23.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 141.00 Cr.. The value appears to be declining and may need further review. It has decreased from 145.00 Cr. (Mar 2025) to 141.00 Cr., marking a decrease of 4.00 Cr..
- For CWIP, as of Sep 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 54.00 Cr., marking an increase of 38.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 158.00 Cr.. The value appears to be declining and may need further review. It has decreased from 169.00 Cr. (Mar 2025) to 158.00 Cr., marking a decrease of 11.00 Cr..
- For Total Assets, as of Sep 2025, the value is 353.00 Cr.. The value appears strong and on an upward trend. It has increased from 330.00 Cr. (Mar 2025) to 353.00 Cr., marking an increase of 23.00 Cr..
However, the Borrowings (152.00 Cr.) are higher than the Reserves (129.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Free Cash Flow | -8.00 | -36.00 | -137.00 | -161.00 | -93.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Debtor Days | 17 | 15 | 17 | 25 | 26 |
| Inventory Days | 72 | 95 | 98 | 125 | 60 |
| Days Payable | 8 | 12 | 21 | 33 | 20 |
| Cash Conversion Cycle | 81 | 98 | 94 | 117 | 66 |
| Working Capital Days | 42 | 34 | 37 | 26 | 14 |
| ROCE % | 14% | 3% | 3% | 19% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 23.25 | -0.89 | 0.93 | 7.38 | 8.31 |
| Diluted EPS (Rs.) | 23.25 | -0.89 | 0.93 | 7.38 | 8.31 |
| Cash EPS (Rs.) | 29.19 | 2.13 | 2.07 | 8.52 | 9.40 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.35 | 68.10 | 64.59 | 61.00 | 53.62 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.35 | 68.10 | 64.59 | 61.00 | 53.62 |
| Revenue From Operations / Share (Rs.) | 498.19 | 300.47 | 330.24 | 374.75 | 349.78 |
| PBDIT / Share (Rs.) | 43.00 | 7.68 | 5.49 | 12.78 | 13.15 |
| PBIT / Share (Rs.) | 37.12 | 4.51 | 4.26 | 11.66 | 12.06 |
| PBT / Share (Rs.) | 28.33 | -1.30 | 1.47 | 10.23 | 11.04 |
| Net Profit / Share (Rs.) | 23.32 | -1.03 | 0.84 | 7.40 | 8.31 |
| NP After MI And SOA / Share (Rs.) | 23.32 | -1.03 | 0.84 | 7.40 | 8.31 |
| PBDIT Margin (%) | 8.63 | 2.55 | 1.66 | 3.41 | 3.75 |
| PBIT Margin (%) | 7.45 | 1.50 | 1.28 | 3.11 | 3.44 |
| PBT Margin (%) | 5.68 | -0.43 | 0.44 | 2.73 | 3.15 |
| Net Profit Margin (%) | 4.68 | -0.34 | 0.25 | 1.97 | 2.37 |
| NP After MI And SOA Margin (%) | 4.68 | -0.34 | 0.25 | 1.97 | 2.37 |
| Return on Networth / Equity (%) | 25.52 | -1.52 | 1.30 | 12.13 | 15.49 |
| Return on Capital Employeed (%) | 24.71 | 3.32 | 3.09 | 17.91 | 20.85 |
| Return On Assets (%) | 9.40 | -0.45 | 0.40 | 5.66 | 8.67 |
| Long Term Debt / Equity (X) | 0.58 | 0.94 | 1.07 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 1.22 | 1.87 | 1.74 | 0.66 | 0.30 |
| Asset Turnover Ratio (%) | 2.08 | 1.41 | 1.95 | 3.31 | 0.00 |
| Current Ratio (X) | 1.22 | 1.24 | 1.53 | 1.59 | 2.06 |
| Quick Ratio (X) | 0.57 | 0.47 | 0.57 | 0.46 | 0.64 |
| Inventory Turnover Ratio (X) | 7.37 | 4.43 | 3.61 | 4.70 | 0.00 |
| Interest Coverage Ratio (X) | 4.89 | 1.32 | 1.97 | 8.96 | 12.85 |
| Interest Coverage Ratio (Post Tax) (X) | 3.65 | 0.82 | 1.30 | 6.19 | 9.12 |
| Enterprise Value (Cr.) | 601.08 | 422.48 | 433.31 | 295.48 | 112.19 |
| EV / Net Operating Revenue (X) | 0.90 | 1.06 | 1.04 | 0.62 | 0.25 |
| EV / EBITDA (X) | 10.51 | 41.33 | 62.37 | 18.26 | 6.74 |
| MarketCap / Net Operating Revenue (X) | 0.68 | 0.63 | 0.70 | 0.52 | 0.20 |
| Price / BV (X) | 3.75 | 2.81 | 3.61 | 3.23 | 1.36 |
| Price / Net Operating Revenue (X) | 0.68 | 0.63 | 0.70 | 0.52 | 0.20 |
| EarningsYield | 0.06 | -0.01 | 0.00 | 0.03 | 0.11 |
After reviewing the key financial ratios for Modi Naturals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 23.25. This value is within the healthy range. It has increased from -0.89 (Mar 24) to 23.25, marking an increase of 24.14.
- For Diluted EPS (Rs.), as of Mar 25, the value is 23.25. This value is within the healthy range. It has increased from -0.89 (Mar 24) to 23.25, marking an increase of 24.14.
- For Cash EPS (Rs.), as of Mar 25, the value is 29.19. This value is within the healthy range. It has increased from 2.13 (Mar 24) to 29.19, marking an increase of 27.06.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.35. It has increased from 68.10 (Mar 24) to 91.35, marking an increase of 23.25.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.35. It has increased from 68.10 (Mar 24) to 91.35, marking an increase of 23.25.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 498.19. It has increased from 300.47 (Mar 24) to 498.19, marking an increase of 197.72.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 43.00. This value is within the healthy range. It has increased from 7.68 (Mar 24) to 43.00, marking an increase of 35.32.
- For PBIT / Share (Rs.), as of Mar 25, the value is 37.12. This value is within the healthy range. It has increased from 4.51 (Mar 24) to 37.12, marking an increase of 32.61.
- For PBT / Share (Rs.), as of Mar 25, the value is 28.33. This value is within the healthy range. It has increased from -1.30 (Mar 24) to 28.33, marking an increase of 29.63.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 23.32. This value is within the healthy range. It has increased from -1.03 (Mar 24) to 23.32, marking an increase of 24.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.32. This value is within the healthy range. It has increased from -1.03 (Mar 24) to 23.32, marking an increase of 24.35.
- For PBDIT Margin (%), as of Mar 25, the value is 8.63. This value is below the healthy minimum of 10. It has increased from 2.55 (Mar 24) to 8.63, marking an increase of 6.08.
- For PBIT Margin (%), as of Mar 25, the value is 7.45. This value is below the healthy minimum of 10. It has increased from 1.50 (Mar 24) to 7.45, marking an increase of 5.95.
- For PBT Margin (%), as of Mar 25, the value is 5.68. This value is below the healthy minimum of 10. It has increased from -0.43 (Mar 24) to 5.68, marking an increase of 6.11.
- For Net Profit Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 5. It has increased from -0.34 (Mar 24) to 4.68, marking an increase of 5.02.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 8. It has increased from -0.34 (Mar 24) to 4.68, marking an increase of 5.02.
- For Return on Networth / Equity (%), as of Mar 25, the value is 25.52. This value is within the healthy range. It has increased from -1.52 (Mar 24) to 25.52, marking an increase of 27.04.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.71. This value is within the healthy range. It has increased from 3.32 (Mar 24) to 24.71, marking an increase of 21.39.
- For Return On Assets (%), as of Mar 25, the value is 9.40. This value is within the healthy range. It has increased from -0.45 (Mar 24) to 9.40, marking an increase of 9.85.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has decreased from 0.94 (Mar 24) to 0.58, marking a decrease of 0.36.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.22. This value exceeds the healthy maximum of 1. It has decreased from 1.87 (Mar 24) to 1.22, marking a decrease of 0.65.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.08. It has increased from 1.41 (Mar 24) to 2.08, marking an increase of 0.67.
- For Current Ratio (X), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 1.5. It has decreased from 1.24 (Mar 24) to 1.22, marking a decrease of 0.02.
- For Quick Ratio (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 24) to 0.57, marking an increase of 0.10.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.37. This value is within the healthy range. It has increased from 4.43 (Mar 24) to 7.37, marking an increase of 2.94.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.89. This value is within the healthy range. It has increased from 1.32 (Mar 24) to 4.89, marking an increase of 3.57.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.65. This value is within the healthy range. It has increased from 0.82 (Mar 24) to 3.65, marking an increase of 2.83.
- For Enterprise Value (Cr.), as of Mar 25, the value is 601.08. It has increased from 422.48 (Mar 24) to 601.08, marking an increase of 178.60.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has decreased from 1.06 (Mar 24) to 0.90, marking a decrease of 0.16.
- For EV / EBITDA (X), as of Mar 25, the value is 10.51. This value is within the healthy range. It has decreased from 41.33 (Mar 24) to 10.51, marking a decrease of 30.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.68, marking an increase of 0.05.
- For Price / BV (X), as of Mar 25, the value is 3.75. This value exceeds the healthy maximum of 3. It has increased from 2.81 (Mar 24) to 3.75, marking an increase of 0.94.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.68, marking an increase of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.06, marking an increase of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Modi Naturals Ltd:
- Net Profit Margin: 4.68%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.71% (Industry Average ROCE: 14.31%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 25.52% (Industry Average ROE: 12.9%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.65
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 12.8 (Industry average Stock P/E: 149.61)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.68%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Edible Oils & Solvent Extraction | 405, Deepali Building, New Delhi Delhi 110019 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anil Modi | Chairman & Managing Director |
| Mr. Akshay Modi | Joint Managing Director |
| Mrs. Aditi Modi | Whole Time Director |
| Mr. Ankit Garg | Independent Director |
| Mrs. Ankita Singal | Independent Director |
| Mr. Udit Jain | Independent Director |
FAQ
What is the intrinsic value of Modi Naturals Ltd?
Modi Naturals Ltd's intrinsic value (as of 18 January 2026) is ₹424.19 which is 20.51% higher the current market price of ₹352.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹468 Cr. market cap, FY2025-2026 high/low of ₹610/320, reserves of ₹129 Cr, and liabilities of ₹353 Cr.
What is the Market Cap of Modi Naturals Ltd?
The Market Cap of Modi Naturals Ltd is 468 Cr..
What is the current Stock Price of Modi Naturals Ltd as on 18 January 2026?
The current stock price of Modi Naturals Ltd as on 18 January 2026 is ₹352.
What is the High / Low of Modi Naturals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Modi Naturals Ltd stocks is ₹610/320.
What is the Stock P/E of Modi Naturals Ltd?
The Stock P/E of Modi Naturals Ltd is 12.8.
What is the Book Value of Modi Naturals Ltd?
The Book Value of Modi Naturals Ltd is 107.
What is the Dividend Yield of Modi Naturals Ltd?
The Dividend Yield of Modi Naturals Ltd is 0.00 %.
What is the ROCE of Modi Naturals Ltd?
The ROCE of Modi Naturals Ltd is 18.7 %.
What is the ROE of Modi Naturals Ltd?
The ROE of Modi Naturals Ltd is 29.2 %.
What is the Face Value of Modi Naturals Ltd?
The Face Value of Modi Naturals Ltd is 10.0.